OALib Journal期刊
ISSN: 2333-9721
费用:99美元
|
|
|
高原低氧影响药物代谢的研究进展
, PP. 1073-1079
Keywords: 高原,低氧,药物代谢动力学,药物代谢酶
Abstract:
高原具有低氧、低压、强辐射、寒冷、干燥等环境特征,其中低氧是影响人体正常生命活动的主要因素,研究高原低氧条件下的药物代谢特征对于了解药物在高原机体的代谢和消除快慢,并指导高原地区临床合理用药具有重要意义。本文综述了高原低氧对药物代谢的影响,阐述了高原低氧条件下部分药物的代谢特征及药物代谢酶活性和表达的变化,并探讨了相关机制。
References
[1] | westjb.high-altitudemedicine[j].amjrespircritcaremed,2012,186:1229-1237.
|
[2] | eiderp,asplundca.altitudeillness:updateonpreventionandtreatment[j].currsportsmedrep,2012,11:124-130.
|
[3] | zafrenk.preventionofhighaltitudeillness[j].travelmedinfectdis,2014,12:29-39.
|
[4] | netzern,strohlk,faulhaberm,etal.hypoxia-relatedaltitudeillnesses[j].jtravelmed,2013,20:247-255.
|
[5] | simonrb,simonda.illnessathighaltitudes[j].nursing,2014,44:36-44.
|
[6] | imrayc,wrighta,subudhia,etal.acutemountainsickness:pathophysiology,prevention,andtreatment[j].progcardiovascdis,2010,52:467-484.
|
[7] | dusouichp.effectofhypercapniaacuteandchromicmoderatehypoxiaondiltiazemkineticsandmetabolisminthedog[j].pharmacology,1993,47:378-385.
|
[8] | zhangjh,wangr,xieh,etal.effectsofaminophyllineonthepharmacokineticparametersathighaltitude[j].pharmjchinpla(解放军药学学报),2014,30:125-131.
|
[9] | anjanagv,krishnak,joginderd.effectofintermittenthypobarichypoxiaonefficacyandclearanceofdrug[j].indianjmedres,2012,135:211-216.
|
[10] | shefalig,gauravkk,asheeshg.hepaticmetabolismofibuprofeninratsunderacutehypobarichypoxia[j].exptoxicolpathol,2013,65:751-758.
|
[11] | dusouichp.effectofhypercapniaand/orhypoxemiaandmetabolicacidosisonkineticsandconcentrationofphenytoininthecerebrospinalfluidofconsciousrabbits[j].neuropharmacology,1986,25:857-862.
|
[12] | streitm,goggelmannc,dehnertc,etal.cytochromep450enzyme-mediateddrugmetabolismatexposuretoacutehypoxia(correspondingtoanaltitudeof4500m)[j].eurjclinpharmacol,2005,61:39-46.
|
[13] | arancibiaa,nellagaim,paulosc,etal.effectsofhighaltitudeexposureonthepharmacokineticsoffurosemideinhealthyvolunteers[j].intjclinpharmther,2004,42:314-320.
|
[14] | preissnersc,hoffmannmf,preissnerr,etal.polymorphiccytochromep450enzymes(cyps)andtheirroleinpersonalizedtherapy[j].plosone,2013,8:e82562.
|
[15] | sevrioukovaif,poulostl.understandingthemechanismofcytochromep4503a4:recentadvancesandremainingproblems[j].daltontrans,2013,42:3116-3126.
|
[16] | proulxm,dusouichp.acutemoderatehypoxiainconsciousrabbits:effectonhepaticcytochromep450andonreactiveoxygenspecies[j].jpharmpharmacol,1995,47:392-397.
|
[17] | kurdij,mauriceh,el-kadiao,etal.effectofhypoxiaaloneorcombinedwithinflammationand3-methylcholanthreneonhepaticcytochromep450inconsciousrabbits[j].brjpharmacol,1999,128:365-373.
|
[18] | fradettec,yamaguchin,dusouichp.5-hydroxytryptamineisbiotransformedbycyp2c9,2c19and2b6tohydroxylamine,whichisconvertedintonitricoxide[j].brjpharmacol,2004,141:407-414.
|
[19] | fradettec,dusouichp.hypoxia-induciblefactor-1andactivatorprotein-1modulatetheupregulationofcyp3a6inducedbyhypoxia[j].brjpharmacol,2003,140:1146-1154.
|
[20] | jürgensg,christensenhr,lofts,etal.acutehypoxiaandcytochromep450-mediatedhepaticdrugmetabolisminhumans[j].clinpharmacolther,2002,71:214-220.
|
[21] | yangm,zhujb,liyp,etal.theeffectofhighaltitudehypoxiaonnat2activityinrats[j].jqinghaimedcoll(青海医学院学报),2013,34:79-83.
|
[22] | haoy,wangr,xieh,etal.influenceofplateauenvironmentonenzymeactivityofcytochrome-p450indrugmetabolismanditsprogress[j].chinjpharmacoltoxicol(中国药理学与毒理学杂志),2013,27:898-902.
|
[23] | dusouichp,fradettec.theeffectandclinicalconsequencesofhypoxiaoncytochromep450,membranecarrierproteinsactivityandexpression[j].expertopindrugmetabtoxicol,2011,7:1083-1100.
|
[24] | rothrajr,rubinrj.roleofbloodflowincarbonmonoxideandhypoxichypoxia-inducedalterationsinhexobarbitalmetabolisminrats[j].drugmetabdispos,1976,4:460-467.
|
[25] | dusouichp,saunierc,hartemannd,etal.effectofacuteandchronicmoderatehypoxiaonthekineticsoflidocaineanditsmetabolitesandonregionalbloodflow[j].pulmpharmacol,1992,5:9-16.
|
[26] | frandettec,bleauam,pichettev,etal.hypoxia-induceddown-regulationofcyp1a1/1a2andup-regulationofcyp3a6involvesserummediators[j].brjpharmacol,2002,137:881-891.
|
[27] | morganet.impactofinfectiousandinflammatorydiseaseoncytochromep450-mediateddrugmetabolismandpharmacokinetics[j].clinpharmacolther,2009,85:434-438.
|
[28] | morganet.regulationofcytochromep450byinflammatorymediators:whyandhow[j].drugmetabdispos,2001,29:207-212.
|
[29] | merryhe,phelanp,doaksm,etal.functionalrolesoftumornecrosisfactor-alphaandinterleukin1-betainhypoxiaandreoxygenation[j].annthoracsurg,2015,99:1200-1205.
|
[30] | cokicbb,cokicvp,sureshs,etal.nitricoxideandhypoxiastimulateerythropoietinreceptorviamapkkinaseinendothelialcells[j].microvascres,2014,92:34-40.
|
[31] | wengerrh.cellularadaptationtohypoxia:o2-sensingproteinhydroxylases,hypoxia-inducibletranscriptionfactors,ando2-regulatedgeneexpression[j].fasebj,2002,16:1151-1162.
|
[32] | eunjungl,sujiny,seungkl,etal.twotransactivationdomainsofhypoxia-induciblefactor-1alpharegulatedbythemek-1-p42-p44mapkpathway[j].molcells,2002,14:9-15.
|
[33] | parkh.aromatichydrocarbonnucleartranslocatorasacommoncomponentforthehypoxia-anddioxin-inducedgeneexpression[j].molcells,1999,9:172-178.
|
[34] | arnesent,kongx,evjenthr,etal.interactionbetweenhif-1alpha(odd)andhard1doesnotinduceacetylationanddestabilizationofhif-1alpha[j].febslett,2005,579:6428-6432.
|
[35] | fisherts,etagessd,hayesl,etal.analysisofard1functioninhypoxiaresponseusingretroviralrnainterference[j].jbiolchem,2005,280:17749-17757.
|
[36] | rahmanms,thomasp.effectsofhypoxiaexposureonhepaticcytochromep4501a(cyp1a)expressioninatlanticcroaker:molecularmechanismsofcyp1adown-regulation[j].plosone,2012,7:e40825.
|
[37] | handschinc,meyerua.inductionofdrugmetabolism:theroleofnuclearreceptors[j].pharmacolrev,2003,55:649-673.
|
[38] | tienes,eegishim.nuclearreceptorscarandpxrintheregulationofhepaticmetabolism[j].xenobiotica,2006,36:1152-1163.
|
[39] | vyhlidalca,poganpk,leederjs.developmentandrefinementofpregnanexreceptor(pxr)dnabindingsitemodelusinginformationtheory:insightsintopxr-mediatedgeneregulation[j].biolchem,2004,279:46779-46786.
|
[40] | legendrec,horit,loyerp,etal.drug-metabolisingenzymesaredown-regulatedbyhypoxiaindifferentiatedhumanhepatomahepargcells:hif-lαinvolvementincyp3a4repression[j].eurjcancer,2009,45:2882-2892.
|
[41] | fradettec,dusouichp.effectofhypoxiaoncytochromep450activityandexpression[j].currdrugmetab,2004,5:257-271.
|
[42] | pennardta.high-altitudepulmonaryedema:diagnosis,prevention,andtreatment[j].currsportsmedrep,2013,12:115-119.
|
[43] | lixy,gaof,lizq,etal.comparisonofthepharmacokineticsofsulfamethoxazoleinmalechinesevolunteersatlowaltitudeandacuteexposuretohighaltitudeversussubjectslivingchronicallyathighaltitude:anopen-labeled,controlled,prospectivestudy[j].clinther,2009,31:2744-2754.
|
[44] | arancibiaa,gaimn,chávezj,etal.pharmacokineticsofprednisoloneinmanduringacuteandchronicexposuretohighaltitude[j].intjclinpharmther,2005,43:85-91.
|
[45] | lixy.pharmacokineticsstudyofsulfamethoxazoleunderhypoxiaenvironmentathighaltitude(高原低氧环境中磺胺甲噁唑的药物动力学研究)[d].shenyang:shenyangpharmaceuticaluniversity,2010.
|
[46] | powelljr,vozehs,hopewellp,etal.theophyllinedispositioninacutelyillhospitalizedpatient[j].amrevrespirdis,1978,118:229-238.
|
[47] | richerm,lamyw.hypoxia,arterialphandtheophyllinedisposition[j].clinpharmacokinet,1993,25:283-299.
|
[48] | letartel,dusouichp.influenceofhypercapniaand/orhypoxemiaandmetabolicacidosisontheophyllinekineticsinconsciousrabbits[j].amrevrespirdis,1984,129:762-766.
|
[49] | zhangjh,wangr,xieh,etal.effectofacuteexposuretohighaltitudeonpharmacokineticsofpropranololandmetoprololinrats[j].jsouthmeduniv(南方医科大学学报),2014,34:1616-1620.
|
[50] | lixy,liuyn,liyp,etal.pharmacokineticstudyofsulfamethoxazoleinhealthyhanvolunteerslivingatplainandnativehanandtibetanhealthyvolunteerslivingathighaltitude[j].actapharmsin(药学学报),2011,46:1117-1122.
|
[51] | fradettec,batongaj,tengs,etal.animalmodelsofacutemoderatehypoxiaareassociatedwithadown-regulationofcyp1a1,1a2,2b4,2c5,and2c16andup-regulationofcyp3a6andp-glycoproteininliver[j].drugmetabdispos,2007,35:765-771.
|
[52] | lixy,wangxj,liyp,etal.effectofexposuretoacuteandchronichigh-altitudehypoxiaontheactivityandexpressionofcyp1a2,cyp2d6,cyp2c9,cyp2c19andnat2inrats[j].pharmacology,2014,93:76-83.
|
[53] | lixy,wangxj,liyp,etal.theactivity,protein,andmrnaexpressionofcyp2e1andcyp3a1inratsafterexposuretoacuteandchronichighaltitudehypoxia[j].highaltmedbiol,2014,15:491-496.
|
[54] | lixy,liuyn,yuanm,etal.theeffectofhighaltitudehypoxiaontheactivityandproteinexpressionofcyp2c9andcyp2c19[j].actapharmsin(药学学报),2012,47:188-193.
|
[55] | morganet,li-masterst,chengpy.mechanismsofcytochromep450regulationbyinflammatorymediators[j].toxicology,2002,181-182:207-210.
|
[56] | bighamaw,leefs.humanhigh-altitudeadaptation:forwardgeneticsmeetsthehifpathway[j].genesdev,2014,28:2189-2204.
|
[57] | jild,qiuyq,xuj,etal.geneticadaptationofthehypoxia-induciblefactorpathwaytooxygenpressureamongeurasianhumanpopulations[j].molbiolevol,2012,29:3359-3370.
|
[58] | cheny,fergusonss,negishim,etal.inductionofhumancyp2c9byrifampicinhyperforinandphenobarbitalismediatedbythepregnanexreceptor[j].jpharmacolexpther,2004,308:495-501.
|
[59] | hubf,bihe,huangm.advancesintheresearchofpregnanexreceptorandconstitutiveandrostanereceptor[j].actapharmsin(药学学报),2011,46:1173-1177.
|
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|